If its almost time for your next dose, skip the missed dose and continue with your regular schedule
Mol Med Rep 12:14851492 Lenehan PF, Gutierrez PL, Wagner JL, Milak N, Fisher GR, Ross DD (1995) Ross resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells
Requires qualified healthcare professional administration
Vegan: with vegan capsule shell and no dyes or preservatives
According to statistics, there are currently approximately 50 million people living with AD worldwide, and this number is expected to increase to 152 million by 2050 as the population ages, making it a major challenge for global public health (Dissanayaka et al., 2024)